Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis
Shenghao Jin, Huiwu Zhao, Yan Yi, Yuji Nakata, Anna Kalota, Alan M. Gewirtz
Shenghao Jin, Huiwu Zhao, Yan Yi, Yuji Nakata, Anna Kalota, Alan M. Gewirtz
View: Text | PDF
Research Article Hematology

c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis

  • Text
  • PDF
Abstract

Mixed-lineage leukemia (MLL) is a proto-oncogene frequently involved in chromosomal translocations associated with acute leukemia. These chromosomal translocations commonly result in MLL fusion proteins that dysregulate transcription. Recent data suggest that the MYB proto-oncogene, which is an important regulator of hematopoietic cell development, has a role in leukemogenesis driven by the MLL-ENL fusion protein, but exactly how is unclear. Here we have demonstrated that c-Myb is recruited to the MLL histone methyl transferase complex by menin, a protein important for MLL-associated leukemic transformation, and that it contributes substantially to MLL-mediated methylation of histone H3 at lysine 4 (H3K4). Silencing MYB in human leukemic cell lines and primary patient material evoked a global decrease in H3K4 methylation, an unexpected decrease in HOXA9 and MEIS1 gene expression, and decreased MLL and menin occupancy in the HOXA9 gene locus. This decreased occupancy was associated with a diminished ability of an MLL-ENL fusion protein to transform normal mouse hematopoietic cells. Previous studies have shown that MYB expression is regulated by Hoxa9 and Meis1, indicating the existence of an autoregulatory feedback loop. The finding that c-Myb has the ability to direct epigenetic marks, along with its participation in an autoregulatory feedback loop with genes known to transform hematopoietic cells, lends mechanistic and translationally relevant insight into its role in MLL-associated leukemogenesis.

Authors

Shenghao Jin, Huiwu Zhao, Yan Yi, Yuji Nakata, Anna Kalota, Alan M. Gewirtz

×

Figure 7

The interaction between c-Myb and the menin-MLL complex is required for localization of MLL and menin on the HOXA9 gene, transformation of myeloid progenitors, and HOXA9 gene expression.

Options: View larger image (or click on image) Download as PowerPoint
The interaction between c-Myb and the menin-MLL complex is required for ...
(A) Schematic representation of the constructions used. DBD, DNA binding domain; TA, transactivation domain; NRD, negative regulation domain. Various c-Myb mutants containing FLAG tag at their N termini and Xpress-tagged menin were transiently transfected in 293T cells. Cell lysates prepared from transfectants were subjected to IP with anti-FLAG M2 agarose. High-affinity menin-binding capacities are indicated on the right. (B and C) Immunoprecipitated proteins were separated by 10% SDS-PAGE and immunoblotted with anti-FLAG antibody (upper panel) or anti-Xpress antibody (bottom panel) antibody. (D) F–c-Myb mutants, menin, and 35S-labeled F–MLL-N were generated by in vitro transcription/translation. c-Myb was incubated with protein reaction mixtures as indicated on the right in the presence of α-FLAG M2 agarose. Samples were resolved on 10% SDS-PAGE, amplified, dried, and fluorographed. (E) ChIP assay of HL-60 cells transfected with c-Myb mutants was performed using the antibodies indicated at the top. Amplicons upstream of the HOXA9 and GAPDH genes were analyzed. (F) CFU per 104 plated cells are shown for each round of plating. Error bars represent standard deviations of 3 independent experiments. (G) Relative expression levels of HOXA9 gene are shown in SEM-K2 cells transfected with c-Myb or its mutants. Error bars represent the standard deviation of assays performed in triplicate.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts